Your browser doesn't support javascript.
loading
Robotic sentinel lymph node dissection experiences in endometrial cancer at our tertiary cancer treatment institution.
Simsek, Erkan; Gündüz, Sadik; Yildiz, Özge Akdeniz; Serhanoglu, Zinar; Yasar, Levent.
Afiliação
  • Simsek E; University of Health Sciences Turkey, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - Istanbul, Turkey.
  • Gündüz S; University of Health Sciences Turkey, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - Istanbul, Turkey.
  • Yildiz ÖA; University of Health Sciences Turkey, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - Istanbul, Turkey.
  • Serhanoglu Z; Kirikhan State Hospital, Gynecology and Obstetrics Clinic - Antakya, Turkey.
  • Yasar L; University of Health Sciences Turkey, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - Istanbul, Turkey.
Rev Assoc Med Bras (1992) ; 70(9): e20240696, 2024.
Article em En | MEDLINE | ID: mdl-39292092
ABSTRACT

OBJECTIVE:

In endometrial cancer surgery, sentinel lymph node dissection is used instead of staging surgery, particularly in advanced disease that is limited to the uterus. The aim of this study is to evaluate our practice of robotic sentinel lymph node dissection, which is applied to endometrial cancer patients in our tertiary cancer treatment center, according to the current literature, and to share our own data.

METHODS:

Included in our analysis are patients who underwent robotic sentinel lymph node dissection for endometrial cancer utilizing indocyanine green in our center between January 2018 and January 2024.

RESULTS:

In all, of the 93 endometrial carcinoma patients who underwent sentinel lymph node biopsy, 63 were classified as low-risk, while 30 were high-risk according to the European Society of Gynaecological Oncology and National Comprehensive Cancer Network guidelines. We found sentinel lymph nodes in both low-risk and high-risk patients, with an overall sensitivity of 96.32% (95% confidence interval [CI], 85.12-99.71), specificity of 100% (95%CI, 92.20-99.8), negative predictive value of 96.72% (95%CI, 87.03-99.89), and negative likelihood ratio of 0.06 (95%CI, 0.01-0.36).

CONCLUSION:

After evaluating our data retrospectively, we determined that we were compatible with the current literature.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Biópsia de Linfonodo Sentinela / Centros de Atenção Terciária / Procedimentos Cirúrgicos Robóticos Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Biópsia de Linfonodo Sentinela / Centros de Atenção Terciária / Procedimentos Cirúrgicos Robóticos Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia País de publicação: Brasil